283 related articles for article (PubMed ID: 9119161)
1. Issues of biological assays for viral vaccines.
Lee CK
Dev Biol Stand; 1996; 88():41-7. PubMed ID: 9119161
[TBL] [Abstract][Full Text] [Related]
2. Detection of adventitious viruses in biologicals--a rare occurrence.
Nims RW
Dev Biol (Basel); 2006; 123():153-64; discussion 183-97. PubMed ID: 16566443
[TBL] [Abstract][Full Text] [Related]
3. Use of PCR for extranous agent testing in avian vaccines.
Ottiger HP
Dev Biol (Basel); 2002; 111():23-6. PubMed ID: 12678221
[TBL] [Abstract][Full Text] [Related]
4. Mammalian cells and their contaminants.
Minor PD
Dev Biol Stand; 1996; 88():25-9. PubMed ID: 9119147
[No Abstract] [Full Text] [Related]
5. Scope and practicality of in vivo testing for adventitious agents.
Whiteman MD
Dev Biol (Basel); 2006; 123():147-52; discussion 183-97. PubMed ID: 16566442
[TBL] [Abstract][Full Text] [Related]
6. Strategy for adventitious agent assays.
Robertson JS
Dev Biol Stand; 1996; 88():37-40. PubMed ID: 9119160
[TBL] [Abstract][Full Text] [Related]
7. Nonhuman primate diploid cells for vaccine production.
Petricciani JC
Dev Biol Stand; 1976 Dec 13-15; 37():21-5. PubMed ID: 1036399
[TBL] [Abstract][Full Text] [Related]
8. Validation of purification procedures for removing and/or inactivating viruses in biologicals: points to consider.
Vicari G
Dev Biol Stand; 1991; 75():227-32. PubMed ID: 1794625
[TBL] [Abstract][Full Text] [Related]
9. Insect cells as a new substrate for vaccine production.
Dalemans W
Dev Biol (Basel); 2006; 123():235-41; discussion 265-6. PubMed ID: 16566449
[TBL] [Abstract][Full Text] [Related]
10. Plaque purification as a method to mitigate the risk of adventitious-agent contamination in influenza vaccine virus seeds.
Murata H; Macauley J; Lewis AM; Peden K
Vaccine; 2011 Apr; 29(17):3155-61. PubMed ID: 21354480
[TBL] [Abstract][Full Text] [Related]
11. Molecular methods for virus discovery.
Jarrett RF; Johnson D; Wilson KS; Gallagher A
Dev Biol (Basel); 2006; 123():77-88; discussion 119-32. PubMed ID: 16566437
[TBL] [Abstract][Full Text] [Related]
12. Current issues in viral assays and viral clearance evaluation.
Lubiniecki AS
Dev Biol Stand; 1996; 88():9-11. PubMed ID: 9119167
[TBL] [Abstract][Full Text] [Related]
13. Human and animal vaccine contaminations.
Pastoret PP
Biologicals; 2010 May; 38(3):332-4. PubMed ID: 20456974
[TBL] [Abstract][Full Text] [Related]
14. Issues related to harmonization of testing requirements for viral safety.
Hayakawa T
Dev Biol Stand; 1996; 88():15-8. PubMed ID: 9119129
[TBL] [Abstract][Full Text] [Related]
15. Extraneous agents testing for substrates of avian origin and viral vaccines for poultry: current provisions and proposals for future approaches.
Jungbäck C; Motitschke A
Biologicals; 2010 May; 38(3):362-5. PubMed ID: 20335053
[TBL] [Abstract][Full Text] [Related]
16. The need for a standardised cell substrate for virus vaccine production.
Perkins FT
Ann Ist Super Sanita; 1969; 5(1):82-9. PubMed ID: 5382315
[No Abstract] [Full Text] [Related]
17. Laboratory host systems for extraneous agent testing in avian live virus vaccines: problems encountered.
Philipp HC; Kolla I
Biologicals; 2010 May; 38(3):350-1. PubMed ID: 20335050
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the sensitivity of in vitro and in vivo tests for detection of the presence of a bovine viral diarrhoea virus type 1 strain.
Antonis AF; Bouma A; de Bree J; de Jong MC
Vet Microbiol; 2004 Sep; 102(3-4):131-40. PubMed ID: 15327789
[TBL] [Abstract][Full Text] [Related]
19. Tests for RNA tumor viruses in cell substrates used in virus vaccine production.
Petricciani JC; Milstien JB
Dev Biol Stand; 1976 Dec 13-15; 37():229-34. PubMed ID: 73485
[TBL] [Abstract][Full Text] [Related]
20. Monitoring veterinary vaccines for contaminating viruses.
Ottiger HP
Dev Biol (Basel); 2006; 126():309-19; discussion 327. PubMed ID: 17058507
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
